Panel Urges Ban on Narcotic Combo Drugs

August 2009
Pharmaceutical Representative;Aug2009, Vol. 39 Issue 8, p11
The article reports on the recommendation of the advisory groups of the U.S. Food and Drug Administration (FDA) to stop the prescription of combination drugs containing acetaminophen due to liver-induced toxicity risks. It notes the approval of physicians and regulators to ban acetaminophen combination drugs such as Vicodin and Percocet, however, acetaminophen's narcotic component is not included. FDA contends about the high possibility of overdose of prescribed narcotic acetaminophen products.


Related Articles

  • DEADLY PAIN PILLS.  // Consumer Reports;Sep2014, Vol. 79 Issue 9, p19 

    The article discusses the increased use of prescription narcotics and opioids containing the narcotic hydrocodone in the U.S. as of September 2014, including an increased number of U.S. deaths from drug overdose. Topics include the U.S. Food and Drug Administration's December 2013 approval of...

  • On Acetaminophen. MILLER, HENRY I. // Regulation;Winter2009/2010, Vol. 32 Issue 4, p2 

    The article presents the author's views on U.S. Food and Drug Administration (FDA) regulatory proposals addressing the risks from acetaminophen overdose. To reduce the incidence of liver damage associated acetaminophen overdose, the FDA recommends the withdrawal from the market of certain widely...

  • Worse Than the Cure. LOTT, JEREMY // Regulation;Fall2009, Vol. 32 Issue 3, p56 

    The author expresses his views on the possible recommendation of the U.S. Food and Drug Administration (FDA) to regulate the consumption of acetaminophen, also known as Tylenol. He notes that around 400 people die each year from overdosing on the drug, and more than 40,000 are hospitalized. He...

  • The opioid abuse epidemic: How healthcare helped create a crisis. Johnson, Steven Ross // Modern Healthcare;2/15/2016, Vol. 46 Issue 7, p0008 

    The author discusses possible contributions of the healthcare sector to the opioid abuse epidemic in the U.S. Topics explored include changes in prescribing practices which led to this problem acknowledged by Physicians for Responsible Opioid Prescribing executive director Andrew Kolodny, the...

  • All Creatures Great and Small: Properly Medicate Them All. Kim-Jung, Linda // FDA Veterinarian;8/16/2010, Issue 2, p1 

    The article focuses on various cases wherein drug medication errors by medical practitioners may occur on people and in animals by the U.S. Food and Drug Administration (FDA). It mentions how unclear abbreviations on prescriptions may result on the said errors in terms of misinterpretations. It...

  • Effexor label revised due to overdose incidents.  // Drug Topics;11/20/2006, Vol. 150 Issue 22, p10 

    The article reports on a revision to the Overdosage/Human Experience section of the prescribing information for Effexor venlafaxine from Wyeth. The revision follows reports of overdose which occurred in the postmarketing period. According to Wyeth, the incidents occurred predominantly in...

  • FDA vows changes to opioid drug policies. Johnson, Steven Ross // Modern Healthcare;2/8/2016, Vol. 46 Issue 6, p0002 

    The article reports on the decision of the U.S. Food and Drug Administration (FDA) to change its policies on reviewing painkillers and to consider labeling for pediatric use of opioid drugs. Initiatives of the FDA in line with its decision are consultation with independent advisory panels,...

  • Paracetamol overdose.  // Reactions Weekly;3/26/2011, Issue 1344, p25 

    The article describes the case of a 5-month-old female infant who developed liver impairment after receiving an accidental overdose of IV paracetamol.

  • Easy-to-Use Overdose Antidote Earns Fast-Track Approval. Kuehn, Bridget M. // JAMA: Journal of the American Medical Association;4/23/2014, Vol. 311 Issue 16, p1600 

    The article reports that the U.S. Food and Drug Administration (FDA) approved the Evzio, an opioid overdose antidote for outpatients that contain a single dose of naloxone. Topics discussed include the use of naloxone in emergency departments to reverse the effects of an illicit or prescription...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics